Azevan Pharmaceuticals, LLC

AZEVAN PHARMACEUTICALS LLC develops pharmaceuticals for the treatment of central nervous system (CNS) disorders. Their developmental focus has been stress-related effective illness resulting in anxiety and depression, CNS disorders causing aggression, and female health issues. Their lead compound, SRX246 is in a Phase II clinical trial for treatment of Intermittent Explosive Disorder and other mood and behavior disorders.